Discovery of new biomarker in blood could lead to early test for Alzheimer’s disease
NEUROSCIENCE NEWS
Summary: Increased levels of PHGDH exRNA levels were found in the blood approximately two years before people were clinically diagnosed with Alzheimer’s disease.
Source: UCSD
Researchers at the University of California San Diego discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer’s disease. The work could lead to the development of a blood test to identify individuals who will develop the disease years before they show symptoms.
The team published their findings in Current Biology.
No comments:
Post a Comment